These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2463576

  • 1. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia.
    Tonet J, Frank R, Fontaine G, Grosgogeat Y.
    Pacing Clin Electrophysiol; 1988 Nov; 11(11 Pt 2):1984-9. PubMed ID: 2463576
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia].
    Tonet J, Frank R, Fontaine G, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1511-7. PubMed ID: 2573326
    [Abstract] [Full Text] [Related]

  • 3. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 4. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y, Paul VE, Griffith MJ, Sneddon JF, Farrell TG, Ward DE, Camm AJ.
    Am Heart J; 1992 Nov 01; 124(5):1233-40. PubMed ID: 1442491
    [Abstract] [Full Text] [Related]

  • 6. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 7. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F, Scheinman MM, Hess DS.
    Pacing Clin Electrophysiol; 1983 May 01; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [Abstract] [Full Text] [Related]

  • 8. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M.
    Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
    Yazaki Y, Haffajee CI, Gold RL, Bishop RL, Alpert JS.
    Am J Cardiol; 1987 Aug 01; 60(4):293-7. PubMed ID: 3618488
    [Abstract] [Full Text] [Related]

  • 10. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M, Cappato R, Kuck KH.
    J Cardiovasc Pharmacol; 1995 Oct 01; 26(4):627-35. PubMed ID: 8569226
    [Abstract] [Full Text] [Related]

  • 11. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
    Leclercq JF, Coumel P.
    Eur Heart J; 1989 Sep 01; 10 Suppl D():61-7. PubMed ID: 2572422
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN, Saksena S.
    Pacing Clin Electrophysiol; 1989 Nov 01; 12(11):1816-26. PubMed ID: 2478982
    [Abstract] [Full Text] [Related]

  • 13. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 14. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB.
    Am J Cardiol; 1997 Sep 11; 80(5B):3F-9F. PubMed ID: 9291444
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
    Kim SG, Felder SD, Figura I, Johnston DR, Mercando AD, Fisher JD.
    Am J Cardiol; 1987 Jun 01; 59(15):1314-8. PubMed ID: 3591686
    [Abstract] [Full Text] [Related]

  • 16. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME.
    Circulation; 1984 Sep 01; 70(3):451-6. PubMed ID: 6744550
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W, Mletzko R, Manz M, Nitsch J, Lüderitz B.
    Pacing Clin Electrophysiol; 1993 Apr 01; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [Abstract] [Full Text] [Related]

  • 18. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 19. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
    Fananapazir L, Epstein SE.
    Am J Cardiol; 1991 Jan 15; 67(2):175-82. PubMed ID: 1987719
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P, Zado ES, Supple GE, Haqqani HM, Garcia FC, Tschabrunn CM, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley MP, Marchlinski FE.
    Circ Arrhythm Electrophysiol; 2015 Dec 15; 8(6):1413-21. PubMed ID: 26546346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.